Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation (Q38340778)

2 September 2017

title

Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation (English)

1 reference

2 September 2017

0 references

0 references

3

Jürgen Schölmerich

1 reference

2 September 2017

Claudia Hofmann

1

1 reference

2 September 2017

Nadja Dunger

series ordinal

2

1 reference

2 September 2017

Werner Falk

series ordinal

4

1 reference

2 September 2017

Florian Obermeier

series ordinal

5

1 reference

2 September 2017

publication date

1 November 2010

1 reference

Inflammatory Bowel Diseases

2 September 2017

published in

1 reference

2 September 2017

volume

16

1 reference

2 September 2017

issue

11

1 reference

2 September 2017

page(s)

1850-1858

1 reference

Signalling pathways and molecular interactions of NOD1 and NOD2

2 September 2017

cites work

1 reference

The fundamental basis of inflammatory bowel disease

21 January 2018

1 reference

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis

21 January 2018

1 reference

In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis

21 January 2018

1 reference

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation

21 January 2018

1 reference

IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins.

21 January 2018

1 reference

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

21 January 2018

1 reference

Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice

21 January 2018

1 reference

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

21 January 2018

The renaissance of GSK3

1 reference

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

21 January 2018

1 reference

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 January 2018

1 reference

The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells

21 January 2018

1 reference

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

21 January 2018

1 reference

Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue.

21 January 2018

1 reference

CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells

21 January 2018

1 reference

Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta.

21 January 2018

1 reference

Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability

21 January 2018

1 reference

CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21294

1 reference

2 September 2017

1 reference